Figure 2

The prognostic significance of FENDRR in gastric cancer patients. (A) Kaplan–Meier analysis of disease-free survival (DFS) based on FENDRR expression in all 158 patients. (B), (C), and (D) Kaplan–Meier analysis of DFS based on FENDRR expression in gastric cancer patients in stages I-II (B), III (C) and IV (D). (E) Kaplan–Meier analysis of overall survival (OS) based on FENDRR expression in all 158 patients. (F), (G) and (H) Kaplan–Meier analysis of OS based on FENDRR expression in gastric cancer patients in stages I-II (F), III (G) and IV (H).